Skip to main content
Signal8

Telesis Bio, Inc. (TBIO)

Sector: Medical - Devices

Industry: Medical - Devices

Telesis Bio, Inc. logo

Telesis Bio, Inc.

OTC:TBIOHealthcare
+0.00%$0.0100
CLOSED
Mkt Cap$784K
EV-
Float59.35M
O/S78.39M
VOL113 sh
$ Vol$1
RVOL0.20×
Inst Own-
SI<0.1%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution
Telesis Bio, Inc. logoOTC:TBIOClosed$0.0100+0.00%
Historical Data
DateOpenHighLowCloseVolume
Nov 12, 20260.01000.01000.01000.0100113
Nov 9, 20260.01000.01000.01000.01001,325
Nov 6, 20260.01100.01100.01100.0110813
Nov 5, 20260.01200.01200.01200.0120455
Oct 30, 20260.01000.01000.01000.0100100
Oct 15, 20260.03860.03860.03860.0386135
Oct 14, 20260.01100.04000.01100.0400405
Oct 13, 20260.01100.01100.01100.01102,059
Oct 7, 20260.01100.01100.01100.0110205
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
8
HOLD
6
SELL
0
TOTAL14
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
0.0%
Institutional
(0)
0.0%
Insiderⓘ
(0)
0.0%
5%+ Owners
(0)
100.0%
Unattributed (incl. retail)ⓘ
Unattributed (incl. retail)100.0%
Sources: 13D/13GO/S: 78.4M · date not recorded
About

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.

Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis.

It also serves government institutions, contract research organizations, and synthetic biology companies.

The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Key Metrics
Market Cap$783,935
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryMedical - Devices
ExchangeOTC
CountryUSUS
IPO DateSep 30, 2024
Shares Outstanding78.39M
Authorized Shares
Float59.35M
52-Week Range
$0.0010$0.1500
$0.0100(6th percentile)
Volume
Average Daily Volume561
113 today vs 561 avg(-80%)

30d Avg

561

60d Avg

631

90d Avg

1.16K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Telesis Bio, Inc. (OTC: TBIO) traded at $0.0100 on Nov 12, 2026, unchanged from the previous close of $0.0100. 52-week range: $0.0010 to $0.1500. The company is in the Healthcare sector (Medical - Devices).